No Data
No Data
Protara Therapeutics Is Maintained at Outperform by Oppenheimer
Express News | Protara Therapeutics : Oppenheimer Cuts Target Price to $25 From $30
Express News | HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target
Protara Therapeutics Analyst Ratings
Express News | Protara Therapeutics Inc : Guggenheim Cuts Target Price to $20 From $22
Protara Therapeutics | 10-Q: Q2 2024 Earnings Report
No Data